Literature DB >> 6546550

The complete sequence of human preprocalcitonin.

J M Le Moullec, A Jullienne, J Chenais, F Lasmoles, J M Guliana, G Milhaud, M S Moukhtar.   

Abstract

DNA complementary to mRNA extracted from the thyroid glands of patients suffering from medullary carcinoma of the thyroid (MCT), a calcitonin-producing tumour, was inserted in the Pst site of pBR 322 by G-C tailing. The recombinant plasmids were used to transform Escherichia coli DP 50. Ampicillin-resistant clones were screened using a 32P-labelled cDNA to mRNA extracted from a case of MCT particularly rich in calcitonin (CT) mRNA. Positive clones were subsequently rescreened using a 32P poly(T) probe. Eighty clones were thus purified, and the inserts obtained by digestion with PstI were subjected to positive hybridization selection with subsequent translation in vitro. An insert stimulating synthesis of the protein and containing restriction sites compatible with the previously published complete sequence of calcitonin mRNA from rat was sequenced. This cDNA insert contained the entire coding region of 426 bp, 70 bp at the 5'-end, and 295 bp upstream from the poly(A) tail. The complete amino acid sequence of human preprocalcitonin could thus be deduced.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6546550     DOI: 10.1016/0014-5793(84)80839-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  43 in total

Review 1.  Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.

Authors:  Kenneth L Becker; Richard Snider; Eric S Nylen
Journal:  Br J Pharmacol       Date:  2009-11-27       Impact factor: 8.739

2.  Failure of PCT to indicate severe fungal infection in two immunodeficient patients.

Authors:  W Huber; U Schweigart; P Bottermann
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 3.553

3.  Structure and methylation of the human calcitonin/alpha-CGRP gene.

Authors:  P M Broad; A J Symes; R V Thakker; R K Craig
Journal:  Nucleic Acids Res       Date:  1989-09-12       Impact factor: 16.971

4.  The sequence specificity of homeodomain-DNA interaction.

Authors:  C Desplan; J Theis; P H O'Farrell
Journal:  Cell       Date:  1988-09-23       Impact factor: 41.582

5.  Model for tissue specific Calcitonin/CGRP-I RNA processing from in vitro experiments.

Authors:  R A Bovenberg; G J Adema; H S Jansz; P D Baas
Journal:  Nucleic Acids Res       Date:  1988-08-25       Impact factor: 16.971

6.  Structural characterization of a high-molecular-mass form of calcitonin [procalcitonin-(60-116)-peptide] and its corresponding N-terminal flanking peptide [procalcitonin-(1-57)-peptide] in a human medullary thyroid carcinoma.

Authors:  J M Conlon; L Grimelius; L Thim
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

7.  Parental allele specific methylation of the human insulin-like growth factor II gene and Beckwith-Wiedemann syndrome.

Authors:  H Schneid; D Seurin; M P Vazquez; M Gourmelen; S Cabrol; Y Le Bouc
Journal:  J Med Genet       Date:  1993-05       Impact factor: 6.318

Review 8.  Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia.

Authors:  Mirjam Christ-Crain; Steven M Opal
Journal:  Crit Care       Date:  2010-02-08       Impact factor: 9.097

9.  Clinical significance of serum procalcitonin in patients with ulcerative colitis.

Authors:  Shigeo Koido; Toshifumi Ohkusa; Kazuki Takakura; Shunichi Odahara; Shintaro Tsukinaga; Toyokazu Yukawa; Jimi Mitobe; Mikio Kajihara; Kan Uchiyama; Hiroshi Arakawa; Hisao Tajiri
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

10.  Infectious background of febrile advanced lung cancer patients who received chemotherapy.

Authors:  Katsuhiro Masago; Akiko Fukuhara; Yutaka Ito; Yukimasa Hatachi; Kaoru Irisa; Yuichi Sakamori; Yosuke Togashi; Shiro Fujita; Young Hak Kim; Tadashi Mio; Michiaki Mishima
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.